When a patient enters an emergency department (ED) with atrial fibrillation (AFib), the medical team moves through a specific sequence designed to stabilize the person and determine the best course of treatment. This isn't a one-size-fits-all process—what happens depends heavily on how the patient presents, how long they've had AFib symptoms, and what other medical conditions they have.
Learn About Paying Your FGUA Bill Online →
The first minutes matter. A patient with new-onset AFib might report chest discomfort, shortness of breath, dizziness, or a racing heartbeat they've never experienced before. Others arrive after experiencing AFib for hours or even days. Emergency physicians need to distinguish between these scenarios because the treatment path differs significantly. A person with AFib that started three hours ago may face different urgency considerations than someone whose AFib began a week ago.
The ED team typically performs these initial steps: a 12-lead electrocardiogram (ECG) is obtained within minutes to confirm AFib and check for other heart problems, vital signs are measured continuously, and blood work is ordered to assess kidney function, electrolyte levels, and markers of heart stress. Oxygen saturation is monitored because low oxygen levels can worsen AFib. The patient may receive an IV line for medication administration if needed.
Beyond these immediate measures, the ED physician conducts a thorough history. They ask when symptoms began, whether this is the patient's first episode or a recurring problem, what medications the person takes, and whether they've experienced recent infections, surgeries, or unusual stress. This context shapes everything that follows. A patient with known, previously-treated AFib presents a different clinical picture than someone having their first episode.
Practical takeaway: If you or a family member arrives at an ED with AFib symptoms, having a written list of current medications, previous AFib episodes, and when symptoms started helps the team work more efficiently.
Emergency departments use two fundamentally different approaches to managing AFib, and understanding the distinction clarifies much of what happens during an ED visit. These aren't competing philosophies—rather, they represent different treatment goals depending on the clinical situation.
Free Guide to Pay by Plate Illinois Billing →
Rate control means slowing the heart's rhythm to a more manageable pace while accepting that the heart remains in AFib. The goal is to reduce the heart rate to the 110 to 150 beats-per-minute range or lower, depending on the patient's condition. This approach acknowledges that AFib itself may not be dangerous if the heart rate isn't dangerously fast. Common medications used for rate control in the ED include beta-blockers (like metoprolol), calcium channel blockers (like diltiazem), and digoxin. These drugs work through different mechanisms but all achieve the goal of slowing electrical conduction through the heart's AV node, the gateway that controls how fast the ventricles beat.
Rhythm control aims to convert the heart back to normal sinus rhythm—the regular, coordinated heartbeat pattern. Medications called antiarrhythmic drugs (such as amiodarone or sotalol) or electrical cardioversion (delivering a therapeutic electrical shock) are used for this purpose. Cardioversion is particularly common in ED settings because it can work quickly, sometimes restoring normal rhythm within minutes. However, rhythm control carries different risks and considerations than rate control, which is why the ED team must carefully assess whether attempting rhythm control is appropriate.
The choice between these approaches depends on several factors. How long has the patient been in AFib? People who've been in AFib for more than 48 hours face a particular risk: blood clots can form in the heart's upper chambers. If rhythm control is attempted in this scenario without first "thinning" the blood or confirming no clots exist, a clot could dislodge into the circulation, potentially causing a stroke. This is why patients with AFib lasting more than 48 hours typically receive rate control initially, followed by a period of blood thinner therapy before rhythm control is considered.
Additionally, the ED team considers whether the patient is hemodynamically unstable—meaning the fast heart rate has caused blood pressure to drop, reduced blood oxygen, or triggered chest pain or confusion. In unstable situations, immediate cardioversion may be the preferred first step because it's the fastest way to improve the patient's condition.
Practical takeaway: Knowing whether you've experienced AFib previously and approximately how long your current episode has lasted gives the ED team crucial information that directly affects their treatment strategy.
One of the most important—and sometimes most confusing—aspects of ED-based AFib care involves anticoagulation, or blood thinning therapy. This deserves careful explanation because the logic isn't immediately obvious to patients unfamiliar with AFib.
Free Guide to Mold Removal Methods for Walls →
When the heart is in AFib, it doesn't contract normally. Instead of the organized squeeze that moves blood efficiently, the upper chambers (atria) quiver chaotically. This irregular motion means blood doesn't empty completely from the atria with each heartbeat. Slower-moving or stagnant blood can clot. These clots can dislodge and travel to the brain, causing a stroke. This is why AFib significantly increases stroke risk—studies show that people with AFib have roughly four to five times the stroke risk compared to people without AFib.
The ED team assesses stroke risk using scoring systems like the CHA₂DS₂-VASc score, which weighs factors like age, heart failure, high blood pressure, diabetes, and previous stroke or clot history. Someone with a high score faces substantial stroke risk and likely needs blood thinner therapy. The specific anticoagulant chosen depends on the clinical situation. For acute ED management, unfractionated heparin delivered intravenously is common because it works quickly and can be reversed if needed. Patients are often transitioned to other anticoagulants (like warfarin or direct oral anticoagulants) before leaving the ED or during hospitalization.
Here's where timing matters critically: if a patient has been in AFib for more than 48 hours and hasn't been on anticoagulation, the ED team faces a dilemma. Starting a blood thinner right away reduces future stroke risk but carries a small risk that any existing clots might dislodge and travel. To manage this risk, some patients undergo transesophageal echocardiography (TEE)—a procedure using an ultrasound probe inserted through the esophagus to visualize the heart and check for clots—before blood thinners are started. Others begin anticoagulation cautiously while accepting the small increased risk. The approach depends on the individual patient and the ED physician's judgment.
For patients with paroxysmal AFib (episodes that come and go), or those experiencing their first AFib episode, the anticoagulation decision is more nuanced. The stroke risk must be weighed against the risks of blood thinner therapy itself, which include bleeding. This is why the ED team gathers detailed information about previous bleeding episodes, falls, or other factors that might increase bleeding risk.
Practical takeaway: If you have AFib or experience an AFib episode, knowing your stroke risk factors (age, heart disease, diabetes, high blood pressure, previous stroke) helps you understand why blood thinner therapy may be recommended.
Not all AFib presentations are created equal, and the ED approach differs significantly depending on whether this is the patient's first episode or a recurring problem they've dealt with before.
How to Delete Your Fitbit Account Guide →
New-onset AFib (someone's first experience) triggers a more extensive investigation. The ED team must rule out secondary causes—conditions that triggered AFib rather than representing primary AFib disease. Infections like pneumonia or sepsis can provoke AFib. Thyroid problems, particularly hyperthyroidism, can trigger it. Acute heart attack, heart failure, pulmonary embolism (blood clot in the lungs), and pericarditis (inflammation of the heart's protective sac) can all present with new-onset AFib. Electrolyte imbalances, particularly low potassium or magnesium, can precipitate AFib. Even caffeine overuse or stimulant drugs can cause new-onset AFib.
Because of these possibilities, the ED
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.